Evaluation of Diimine Ligand Exchange on Cu(I)
Inorganic Chemistry, Vol. 40, No. 11, 2001 2545
chromatographed on alumina (40 g), eluting with CH2Cl2/hexanes (1:
1), followed by EtOAc/hexanes (1:1) to obtain 1b (155 mg, 51%) as
white crystals, mp 144-145 °C: 1H NMR (CDCl3) δ 9.20 (d, 1H, J )
3.0 Hz, H9), 8.23 (d, 1H, J ) 6.9 Hz, H7), 7.95 (s, 1H, H4), 7.70 (AB
quartet, 2H, J ) 2.4, 9.0 Hz, H5/H6), 7.60 (quartet, 1H, J ) 3.6 Hz,
H8), 3.96 (broad s, H2O), 3.19 (broad s, 2H, -CH2-), 3.09 (t, 2H, J )
6.9 Hz, -CH2-), 1.73 (t, 2H, J ) 6.9 Hz, -CH2-), 1.09 (s, 6H, CH3);
13C NMR (CDCl3) δ 159.0, 150.0, 145.9, 144.2, 135.9, 135.3, 131.3,
128.2, 127.2, 126.2, 125.3, 122.4, 47.6, 35.4, 30.3, 28.2, 25.9. Anal.
Calcd for C18H18N2‚0.25H2O: C, 81.06; H, 6.94; N, 10.51. Found: C,
81.21; H, 6.30; N, 10.44. MS m/e 262 (M+).
In conclusion, we have shown that a judicious choice of
ligands can provide a means for estimating the barrier for ligand
exchange in Cu(I) diimine type complexes using VT NMR
techniques. For two relatively different types of ligands, 1,10-
phenanthroline and 2,2′-bipyrimidine, these values span a fairly
narrow range of 11.6-14.0 kcal/mol in acetonitrile. This
coordinating solvent facilitates ligand exchange as well as
oxidation of the complex. Bulky substituents which impede
solvent attack lead to higher exchange barriers. The resulting
better understanding of the ligand exchange process should assist
in the design of more efficient and specific self-assembling
ligand-metal complexes. Ideally one can hope for eventual
quantification of factors such as ligand basicity, steric bulk, and
conformation to allow structure-based predictions of self-
assembling tendencies in Cu(I)-based diimine ligand systems.
Further efforts are being directed along these lines.
4,6-Di(p-tolyl)-2-hydroxypyrimidine (6a). To urea (0.6 g, 9.5
mmol) dissolved in absolute EtOH (10 mL) were added 1,3-di(p-tolyl)-
1,3-propanedione (1.2 g, 4.8 mmol) and concentrated HCl (1.2 mL),
and the mixture was refluxed for 24 h. Additional urea (0.3 g, 4.7 mmol)
and concentrated HCl (0.3 mL) were then added and the reflux
continued for an additional 24 h. After cooling, the precipitate was
filtered, washed with CHCl3, triturated with hot acetone, and dried to
yield 6a (0.6 g, 46%) as a yellow powder, mp >270 °C: 1H NMR
(DMSO-d6) δ 8.07 (d, 4H, J ) 8.1 Hz, ArH), 7.60 (s, 1H, dCH-),
7.45 (d, 4H, J ) 8.1 Hz, ArH), 4.80 (s, 1H, -OH), 2.42 (s, 6H, -CH3).
4,6-Di(p-tolyl)-2-chloropyrimidine (6b). A mixture of 6a (410 mg,
1.48 mmol) and N,N-dimethylaniline (3 drops) in POCl3 (12 mL) was
refluxed for 7 h. Excess POCl3 was then removed by distillation under
vacuum. The resulting oil was dissolved in cold water and extracted
with CH2Cl2 (3 × 40 mL). The combined organic layers were dried
over MgSO4, concentrated, and chromatographed on alumina (25 g),
eluting with CH2Cl2, to afford 6b (100 mg, 23%) as a white solid, mp
142-145 °C: 1H NMR (CDCl3) δ 8.05 (d, 4H, J ) 8.1 Hz, ArH),
7.96 (s, 1H, dCH-), 7.33 (d, 4H, J ) 8.1 Hz, ArH), 2.44 (s, 6H,
-CH3).
4,4′,6,6′-Tetra(p-tolyl)-2,2′-bipyrimidine (2d). A mixture of an-
hydrous nickel chloride (89 mg, 0.68 mmol), triphenylphosphine (714
mg, 2.72 mmol), and zinc powder (63.5 mg, 0.97 mmol) was kept under
Ar for 10 min. Freshly distilled DMF (4 mL) was then added, and the
mixture was stirred at 50 °C for 30 min. To the dark red solution was
added 6b (200 mg, 0.68 mmol) in DMF (3 mL). Stirring was continued
for 6 h at 50 °C. After cooling, the reaction mixture was poured into
a mixture of NH4OH (28-30%, 14 mL) and water (36 mL), stirred
overnight, and extracted with CH2Cl2 (3 × 50 mL) in the presence of
EDTA disodium salt (3 g) to break the emulsion. The organic layer
was washed with water (30 mL), dried over MgSO4, and concentrated.
The resulting orange-yellow liquid was chromatographed on silica gel
(25 g) eluting with hexane/EtOAc (4:1). Recrystallization from EtOH
yielded 2d (55 mg, 31%) as a white powder, mp 271-273 °C: 1H
NMR (CDCl3) δ 8.25 (d, 8H, J ) 8.1 Hz, ArH), 8.18 (s, 2H, dCH-),
7.38 (d, 8H, J ) 7.8 Hz, ArH), 2.46 (s, 12H, -CH3); 13C NMR (CDCl3)
δ 165.8, 143.7, 141.2, 134.5, 129.6, 127.5, 111.7, 21.5. Anal. Calcd
for C36H30N4‚1.5H2O: C, 79.27; H, 6.05; N, 10.28. Found: C, 79.37;
H, 5.60; N, 10.15.
Experimental Section
Nuclear magnetic resonance spectra were recorded on a General
1
Electric QE-300 spectrometer at 300 MHz for H NMR and 75 MHz
for 13C NMR. Chemical shifts are reported in parts per million
downfield from Me4Si. Electronic spectra were obtained on a Perkin-
Elmer 330 spectrophotometer. Mass spectra were obtained on a Hewlett-
Packard 5989B mass spectrometer (59987A Electrospray) using the
atmospheric pressure ionization (API) method at a temperature of 160
°C for the complexes and atmospheric pressure chemical ionization
(APCI) at 300 °C for the ligands. Cyclic voltammograms were recorded
using a BAS CV-27 voltammograph or an EG & G Princeton Applied
Research Potientiostat/Galvanostat model 263A and a Houston Instru-
ments model 100 X-Y recorder according to a procedure which has
been described previously.20 All solvents were freshly distilled reagent
grade. Melting points were measured with a capillary melting point
apparatus and are not corrected. Elemental analyses were performed
by National Chemical Consulting, Inc., Tenafly, NJ. The 8-amino-7-
quinolinecarbaldehyde (3),10 4,4′,6,6′-tetramethyl-2,2′-bipyrimidine (2b),21
4,4′,6,6′-tetraphenyl-2,2′-bipyrimidine (2c),22 1,3-di(p-tolyl)-1,3-pro-
panedione (5),23 and [Cu(CH3CN)4]PF6 and [Cu(CH3CN)4]ClO424 were
prepared according to literature procedures. CAUTION! Perchlorate
salts of transition metal complexes containing organic ligands are
potentially explosive and should be prepared in small quantities and
handled with appropriate precautions. While no difficulties were
encountered with the complexes reported herein, due caution should
be exercised.
6,7,8,9-Tetrahydropyrido[1,2-b]acridine (1a). To a solution of
cyclohexanone (57 mg, 0.6 mmol) and 8-amino-7-quinolinecarb-
aldehyde (100 mg, 0.58 mmol) in absolute EtOH (5 mL) was added
saturated ethanolic KOH (0.5 mL). The solution was refluxed under
Ar for 17 h. The solvent was evaporated, and the residue was
chromatographed on alumina (30 g) eluting with CH2Cl2/hexane (7:3)
to give 1a (105 mg, 77%) as a beige solid, mp 116-117 °C: 1H NMR
(CDCl3) δ 9.32 (d, 1H, J ) 3.6 Hz, H9), 8.38 (d, 1H, J ) 7.8 Hz, H7),
8.01 (s, 1H, H4), 7.78 (broad s, 2H, H5/H6), 7.72 (quartet, 1H, J ) 4.5
Hz, H8), 3.58 (broad s, H2O), 3.51 (t, 2H, J ) 6.3 Hz, -CH2), 3.08 (t,
2H, J ) 5.7 Hz, -CH2-), 2.04 (m, 2H, -CH2-), 1.96 (m, 4H, -CH2-
); 13C NMR (CDCl3) δ 157.8, 144.4, 135.5, 133.5, 131.4, 127.8, 127.7,
126.8, 125.2, 125.0, 124.4, 124.4, 33.8, 29.2, 23.5, 23.2; MS m/e 235
(MH+).
[Cu(1a)2]ClO4. Solid [Cu(CH3CN)4]ClO4 (14 mg, 0.043 mmol) was
added to a solution of 1a (20 mg, 0.09 mmol) in CH3CN (7 mL). The
solution became dark red and was stirred at 25 °C under Ar for 1 h.
The solution was concentrated under vacuum and the complex
precipitated as air-stable, deep red crystals (22 mg, 81%): 1H NMR
(CD3CN) δ 8.82 (broad s, 2H, H9), 8.61 (d, 2H, J ) 8.1 Hz, H7), 8.33
(s, 2H, H4), 8.03 (broad s, 4H, H5/H6), 7.84 (quartet, 2H, J ) 4.8 Hz,
H8), 3.08 (t, 4H, J ) 6.0 Hz, -CH2-), 2.71 (broad s, 4H, -CH2-),
2.19 (s, H2O), 1.79 (broad s, 4H, -CH2-), 1.67 (broad s, 4H, -CH2-
); MS m/e 529 (M-ClO4)+. Anal. Calcd for C32H28N4CuClO4: C, 60.87;
H, 4.43; N, 8.88. Found: C, 60.84; H, 4.34; N, 8.70.
8,8-Dimethyl-6,7,9-trihydropyrido[1,2-b]acridine (1b). Following
the procedure described for 1a, 3,3′-dimethylcyclohexanone (147 mg,
1.16 mmol) was condensed with 8-amino-7-quinolinecarbaldehyde (200
mg, 1.16 mmol) in absolute EtOH (12 mL). The crude product was
[Cu(1b)2]ClO4. Following the procedure described for [Cu(1a)2]-
ClO4, 1b (50 mg, 0.2 mmol) was treated with [Cu(CH3CN)4]ClO4 (31
mg, 0.09 mmol) in CH3CN (7 mL) to give the complex as air-stable
deep red crystals (57 mg, 92%): 1H NMR (CD3CN) δ 8.80 (d, 2H, J
) 6.0 Hz, H9), 8.64 (d, 2H, J ) 6.0 Hz, H7), 8.40 (s, 2H, H4), 8.07
(broad s, 4H, H5/H6), 7.84 (quartet, 2H, H8), 3.14 (t, 4H, -CH2-),
2.46 (broad s, 4H, -CH2-), 1.59 (t, 4H, -CH2-), 0.65 (s, 12H, CH3).
Anal. Calcd for C36H36N4CuClO4: C, 62.90; H, 5.24; N, 8.15. Found:
C, 62.79; H, 5.29; N, 7.80.
(20) Goulle, V.; Thummel, R. P. Inorg. Chem. 1990, 29, 1767.
(21) Bly, D. D. J. Org. Chem. 1964, 29, 943.
(22) Nasielski, J.; Standaert, A.; Nasielski-Hinkens, R. Synth. Commun.
1991, 21, 901.
(23) Choschi, T.; Horimoto, S.; Wang, C. Y.; Nagase, H.; Ichikawa, M.;
Sugino, E.; Hibino, S. Chem. Pharm. Bull. 1992, 40, 1047.
(24) (a) Kubas, G. J.; Monzyk, B.; Crumbliss, A. L. Inorg. Synth. 1971,
19, 90. (b) Hemmerich, P.; Sigwart, C. Experientia 1963, 488.